Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

Sep. 26, 1997

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

RenaGel safely and effectively binds phosphate in volunteers

Sep. 24, 1997

Cytoclonal allowed U.S. patent for PKD treatment

Sep. 23, 1997

Abbott investment to fund lupus drug candidate

Sep. 19, 1997

Efficacy of GAX-65 demonstrated in pediatric study

Sep. 19, 1997

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

Sep. 18, 1997

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

Sep. 18, 1997

Gene Logic and Japan Tobacco enter genomic alliance

Sep. 15, 1997

NC-1800 now in phase II development

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...